87 related articles for article (PubMed ID: 18435931)
1. Evidence for multiple peroxisome proliferator-activated receptor gamma transcripts in bone: fine-tuning by hormonal regulation and mRNA stability.
Bruedigam C; Koedam M; Chiba H; Eijken M; van Leeuwen JP
FEBS Lett; 2008 May; 582(11):1618-24. PubMed ID: 18435931
[TBL] [Abstract][Full Text] [Related]
2. The peroxisome proliferator-activated receptor gamma regulates trophoblast cell differentiation in mink (Mustela vison).
Desmarais JA; Lopes FL; Zhang H; Das SK; Murphy BD
Biol Reprod; 2007 Nov; 77(5):829-39. PubMed ID: 17615406
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
Fiatte C; Huin C; Bertin I; Lesuffleur T; Pluvinet A; Touche N; Plénat F; Dauça M; Domenjoud L; Schohn H
Int J Oncol; 2006 Dec; 29(6):1601-10. PubMed ID: 17089002
[TBL] [Abstract][Full Text] [Related]
4. [Increasing alcohol-induced osteogenesis of human bone marrow-derived mesenchymal cells using siRNA transient suppression of peroxisome proliferator activated receptor gamma: an in vitro experiment study].
Zhang H; Cheng JQ; Huang Q; Yang J; Shen B; Zhou ZK; Kang PD; Lian YY; Pei FX
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2603-8. PubMed ID: 19080706
[TBL] [Abstract][Full Text] [Related]
5. Cotranscription and intergenic splicing of the PPARG and TSEN2 genes in cattle.
Roux M; Levéziel H; Amarger V
BMC Genomics; 2006 Apr; 7():71. PubMed ID: 16595010
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone regulation of cFos mRNA in osteoprogenitors.
Shur I; Socher R; Benayahu D
J Cell Physiol; 2005 Jan; 202(1):240-5. PubMed ID: 15389524
[TBL] [Abstract][Full Text] [Related]
7. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
Haydon RC; Luu HH; He TC
Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
[TBL] [Abstract][Full Text] [Related]
8. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
9. PPAR gamma: ally and foe in bone metabolism.
Wahli W
Cell Metab; 2008 Mar; 7(3):188-90. PubMed ID: 18316021
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours.
Costa-Guda J; Rosen ED; Jensen RT; Chung DC; Arnold A
Clin Endocrinol (Oxf); 2005 May; 62(5):603-6. PubMed ID: 15853832
[TBL] [Abstract][Full Text] [Related]
11. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
12. CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.
Wyles CC; Paradise CR; Houdek MT; Slager SL; Terzic A; Behfar A; van Wijnen AJ; Sierra RJ
Clin Orthop Relat Res; 2019 Aug; 477(8):1800-1812. PubMed ID: 31135556
[TBL] [Abstract][Full Text] [Related]
13. Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa.
Voltan S; Martines D; Elli M; Brun P; Longo S; Porzionato A; Macchi V; D'Incà R; Scarpa M; Palù G; Sturniolo GC; Morelli L; Castagliuolo I
Gastroenterology; 2008 Oct; 135(4):1216-27. PubMed ID: 18722375
[TBL] [Abstract][Full Text] [Related]
14. Progesterone is extensively metabolized in osteoblasts: implications for progesterone action on bone.
Quinkler M; Kaur K; Hewison M; Stewart PM; Cooper MS
Horm Metab Res; 2008 Oct; 40(10):679-84. PubMed ID: 18537080
[TBL] [Abstract][Full Text] [Related]
15. Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization.
Seriwatanachai D; Krishnamra N; van Leeuwen JP
J Cell Biochem; 2009 Jul; 107(4):677-85. PubMed ID: 19365811
[TBL] [Abstract][Full Text] [Related]
16. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma.
Zieleniak A; Wójcik M; Woźniak LA
Arch Immunol Ther Exp (Warsz); 2008; 56(5):331-45. PubMed ID: 18836859
[TBL] [Abstract][Full Text] [Related]
17. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton.
Almeida M; Ambrogini E; Han L; Manolagas SC; Jilka RL
J Biol Chem; 2009 Oct; 284(40):27438-48. PubMed ID: 19657144
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
Xiao J; Leung JC; Chan LY; Guo H; Lai KN
Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
